Acura Pharmaceuticals, Inc. (ACUR) Announces First Quarter 2013 Financial Results
5/3/2013 10:47:22 AM
More...
|
Acura Pharmaceuticals, Inc. (ACUR) to Host First Quarter 2013 Financial Results Conference Call on May 3, 2013
4/23/2013 10:49:19 AM
More...
|
Acura Pharmaceuticals, Inc. (ACUR) Awarded U.S. Patent for Abuse Deterrent Drug Formulations
4/5/2013 9:16:13 AM
More...
|
Acura Pharmaceuticals, Inc. (ACUR)' Universal Shelf Registration Statement Declared Effective
3/15/2013 11:31:21 AM
More...
|
Acura Pharmaceuticals, Inc. (ACUR) Reaches Key Milestone With Entrance Into Chain Drug Store Market
3/5/2013 9:27:27 AM
More...
|
Acura Pharmaceuticals, Inc. (ACUR) Announces Fourth Quarter and Full Year 2012 Financial Results
3/5/2013 9:21:29 AM
More...
|
Acura Pharmaceuticals, Inc. (ACUR) to Present at the Cowen and Company Health Care Conference on March 5, 2013
2/22/2013 9:41:02 AM
More...
|
Acura Pharmaceuticals, Inc. (ACUR) Submits Investigational New Drug Application
12/20/2012 8:35:18 AM
More...
|
Acura Pharmaceuticals, Inc. (ACUR) Launches Next Generation Cold Medicine to Aid in the Fight Against Meth
12/10/2012 9:24:10 AM
More...
|
Acura Pharmaceuticals, Inc. (ACUR) Announces Successful Bioequivalent Study for NEXAFED
11/21/2012 11:17:07 AM
More...
|
|